Board Meeting2 Nov 2026, 03:45 pm
Molbio Diagnostics Board Meeting on Nov 5 to Approve Q2 FY27 Results
AI Summary
Molbio Diagnostics Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the unaudited financial results for both standalone and consolidated operations for the quarter and half-year ended September 30, 2026. The trading window for company shares will remain closed from October 1, 2026, until 48 hours after the results are declared. This information is also available on the company's website.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve unaudited financial results for Q2 FY27.
- Results will be for standalone and consolidated financials.
- Trading window closure in effect until results announcement.
Price Impact
More from MOLBIO